Jeffrey B. Ulmer

17.8k total citations · 5 hit papers
143 papers, 13.2k citations indexed

About

Jeffrey B. Ulmer is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Jeffrey B. Ulmer has authored 143 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Immunology, 66 papers in Molecular Biology and 62 papers in Infectious Diseases. Recurrent topics in Jeffrey B. Ulmer's work include Immunotherapy and Immune Responses (50 papers), RNA Interference and Gene Delivery (34 papers) and HIV Research and Treatment (25 papers). Jeffrey B. Ulmer is often cited by papers focused on Immunotherapy and Immune Responses (50 papers), RNA Interference and Gene Delivery (34 papers) and HIV Research and Treatment (25 papers). Jeffrey B. Ulmer collaborates with scholars based in United States, Japan and Switzerland. Jeffrey B. Ulmer's co-authors include John Donnelly, Margaret A. Liu, John W. Shiver, Arthur Friedman, R. Randall Deck, Corrille M. DeWitt, Donna L. Montgomery, Derek T. O’Hagan, Andrew J. Geall and Susan W. Barnett and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jeffrey B. Ulmer

141 papers receiving 12.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein

1993 1.9k citations Jeffrey B. Ulmer, John Donnelly et al. profile →
DNA VACCINES

1997 883 citations John Donnelly, Jeffrey B. Ulmer et al. profile →
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

1996 541 citations R. Randall Deck, Corrille M. DeWitt et al. Nature Medicine profile →
Nonviral delivery of self-amplifying RNA vaccines

2012 525 citations Gillis R. Otten, Derek T. O’Hagan et al. profile →
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases

2019 360 citations Jeffrey B. Ulmer et al. profile →

Peers

Countries citing papers authored by Jeffrey B. Ulmer

Since Specialization

Citations

This map shows the geographic impact of Jeffrey B. Ulmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey B. Ulmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey B. Ulmer more than expected).

Fields of papers citing papers by Jeffrey B. Ulmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey B. Ulmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey B. Ulmer. The network helps show where Jeffrey B. Ulmer may publish in the future.

Co-authorship network of co-authors of Jeffrey B. Ulmer

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey B. Ulmer. A scholar is included among the top collaborators of Jeffrey B. Ulmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey B. Ulmer. Jeffrey B. Ulmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19 2025 ·Frontiers in Immunology ·(unknown), Swayam Prakash, Hawa Vahed, Nisha R. Dhanushkodi, (unknown), Ahmed Belmouden, (unknown), Aziz Alami Chentoufi, (unknown), Jeffrey B. Ulmer, Lbachir BenMohamed	5
2	Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern 2024 ·Frontiers in Immunology ·Swayam Prakash, Nisha R. Dhanushkodi, (unknown), Izabela Coimbra Ibraim, (unknown), (unknown), Delia F. Tifrea, (unknown), (unknown), (unknown), Robert A. Edwards, (unknown), Hawa Vahed, Anthony B. Nesburn, Baruch D. Kuppermann, Jeffrey B. Ulmer, (unknown), Trevor Jones, Lbachir BenMohamed	18
3	What’s next for COVID vaccines? 2024 ·Jeffrey B. Ulmer, Lbachir BenMohamed	1
4	A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4 ⁺ and CD8 ⁺ T cells and enhanced protection against COVID-19-like symptoms and death caused by SARS-CoV-2 infection 2023 ·Journal of Virology ·(unknown), Swayam Prakash, Nisha R. Dhanushkodi, (unknown), Izabela Coimbra Ibraim, (unknown), (unknown), (unknown), (unknown), (unknown), Jennifer Tran, (unknown), (unknown), Kathy Hormi–Carver, Ahmed Belmouden, Hawa Vahed, (unknown), Jeffrey B. Ulmer, Lbachir BenMohamed	9
5	Recent innovations in mRNA vaccines 2016 ·Current Opinion in Immunology ·Jeffrey B. Ulmer, Andrew J Geall	70
6	New developments and concepts related to biomarker application to vaccines 2011 ·Microbial Biotechnology ·Sohail Ahmed, Steve Black, Jeffrey B. Ulmer	3
7	A Therapeutic SIV DNA Vaccine Elicits T-Cell Immune Responses, but No Sustained Control of Viremia in SIVmac239-Infected Rhesus Macaques 2008 ·AIDS Research and Human Retroviruses ·Jan zur Megede, Brigitte E. Sanders-Beer, Peter Silvera, (unknown), (unknown), (unknown), (unknown), (unknown), Ranjana Srivastava, Gillis R. Otten, Dietmar Rabussay, Lei Zhang, Jeffrey B. Ulmer, Susan W. Barnett, John Donnelly	18
8	Heterologous Prime–Boost Strategy to Immunize Very Young Infants against Measles: Pre-clinical Studies in Rhesus Macaques 2007 ·Clinical Pharmacology & Therapeutics ·Marcela F. Pasetti, Aldo Arturo Reséndiz‐Albor, Karina Ramírez, (unknown), Mark Papania, Robert J. Adams, Fernando P. Polack, Brian J. Ward, David S. Burt, Sophie Chabot, Jeffrey B. Ulmer, Eileen M. Barry, Myron M. Levine	27
9	Neonatal Immunization with a Sindbis Virus-DNA Measles Vaccine Induces Adult-Like Neutralizing Antibodies and Cell-Mediated Immunity in the Presence of Maternal Antibodies 2006 ·The Journal of Immunology ·Alejandra Victoria Capozzo, Karina Ramírez, John M. Polo, Jeffrey B. Ulmer, Eileen M. Barry, Myron M. Levine, Marcela F. Pasetti	40
10	Targeting the innate immune response with improved vaccine adjuvants 2005 ·Nature Medicine ·Achal Pashine, Nicholas M. Valiante, Jeffrey B. Ulmer	435
11	Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and C 2005 ·Microbes and Infection ·Susan W. Barnett, Indresh K. Srivastava, Jeffrey B. Ulmer, John Donnelly, Rino Rappuoli	14
12	Tuberculosis DNA Vaccines 2001 ·Scandinavian Journal of Infectious Diseases ·Jeffrey B. Ulmer	9
13	Antigen Presentation and DNA Vaccines 2000 ·American Journal of Respiratory and Critical Care Medicine ·John Donnelly, (unknown), Jeffrey B. Ulmer	89
14	Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo 2000 ·The Journal of Immunology ·Georg Widera, Melissa A. Austin, Dietmar Rabussay, Cheryl Goldbeck, Susan W. Barnett, Minchao Chen, (unknown), Gillis R. Otten, Kent Thudium, Mark Selby, Jeffrey B. Ulmer	445
15	Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice 2000 ·The Journal of Immunology ·Marc Dupuis, Kimberly Denis-Mize, (unknown), Cheryl Goldbeck, Mark Selby, Minchao Chen, Gillis R. Otten, Jeffrey B. Ulmer, John Donnelly, Gary Ott, Donald M. McDonald	261
16	Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells 2000 ·Gene Therapy ·Kimberly Denis-Mize, Marc Dupuis, Mary Lee MacKichan, Manmohan Singh, Barbara Doe, Derek T. O’Hagan, Jeffrey B. Ulmer, John Donnelly, Donald M. McDonald, Gary Ott	130
17	Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity 1997 ·Vaccine ·Jeffrey B. Ulmer	40
18	Generation of MHC class I‐restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non‐muscle cells 1996 ·Immunology ·Jeffrey B. Ulmer, R. Randall Deck, Corrille M. DeWitt, John Donnelly, (unknown)	209
19	Toward the development of DNA vaccines 1996 ·Current Opinion in Biotechnology ·Jeffrey B. Ulmer	51
20	Presentation of an exogenous antigen by major histocompatibility complex class I molecules 1994 ·European Journal of Immunology ·Jeffrey B. Ulmer, John Donnelly, Margaret A. Liu	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact